SEC investigating Illumina over acquisition of cancer test developer Grail

South Africa News News

SEC investigating Illumina over acquisition of cancer test developer Grail
South Africa South Africa Latest News,South Africa South Africa Headlines

Illumina's acquisition of cancer test developer Grail has also faced heavy scrutiny from antitrust regulators in the U.S. and European Union.

  • 📰 CNBC
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 72%

Last month, the SEC informed Illumina about the probe and requested documents and communications related to the. The agency also asked for statements and disclosures about the "conduct and compensation" of certain members of both Illumina and Grail's management, according to the filing.

Illumina's Grail deal has also faced heavy scrutiny from antitrust regulators in the U.S. and European Union.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in ZA
 

South Africa South Africa Latest News, South Africa South Africa Headlines



Render Time: 2025-01-12 14:21:29